Fangyuan Sun

984 citations
26 papers · 349 indexed · h-index 11
Topics
Inflammasome and immune disorders (8 papers)MicroRNA in disease regulation (3 papers)Immune Response and Inflammation (3 papers)
Journals
SHILAP Revista de lepidopterologíaThe Journal of ImmunologyGeochimica et Cosmochimica Acta

In The Last Decade

Fangyuan Sun

21 papers receiving 346 citations

Peers

Fangyuan Sun
Comparison fields: 5 of 83
  • Molecular Biology 164
  • Cancer Research 105
  • Immunology 68
  • Epidemiology 59
  • Critical Care and Intensive Care Medicine 41
Replace Qianpeng Han with:
Qianpeng Han China
Huanzhang Shao China
Xuemin Song China
Nancy Chou MacGarvey United States
Andreia Cunha Portugal
Jiangtao Yin China
Mingran Zhao China
Lara Faggi Italy
Fangyuan Sun relative to Qianpeng Han China Qianpeng Han's profile →
Citations per field
00.5×4.8×
Qianpeng Han · 1×
Citations per year

Countries citing papers authored by Fangyuan Sun

Since Specialization
Citations

This map shows the geographic impact of Fangyuan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyuan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyuan Sun more than expected).

Fields of papers citing papers by Fangyuan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyuan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyuan Sun. The network helps show where Fangyuan Sun may publish in the future.

Co-authorship network of co-authors of Fangyuan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyuan Sun. A scholar is included among the top collaborators of Fangyuan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyuan Sun. Fangyuan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 11
3 0
4 0
5 8
6 1
7 3
8 12
9 3
10 17
11 10
12 24
13 58
14 12
15 27
16 25
17 49
18 54
19 4
20
Transcervical embryo transfer in mice.
16

About Fangyuan Sun

Fangyuan Sun is a scholar working on Marketing, Immunology and Cancer Research, having authored 26 papers that have together received 349 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (8 papers), MicroRNA in disease regulation (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (41 citations), Cancer Research (105 citations) and Applied Microbiology and Biotechnology (11 citations). Fangyuan Sun has collaborated with scholars based in China, United States and Estonia. Frequent co-authors include Ming Lei, Weifang Yuan, Yuxia Sun, Hao Wu, Ming Lei, Huan Geng, Tao Zhang, Gang Chen, Yuan Lin and Wei Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Geochimica et Cosmochimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026